Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
October 23, 1997
In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461
M Van Heek, C F France, D S Compton, et al.
Journal of Medicinal Chemistry
|
July 22, 1994
Mercaptoacyl amino acid inhibitors of atriopeptidase. 1. Structure-activity relationship studies of methionine and S-alkylcysteine derivatives
B R Neustadt, E M Smith, T L Nechuta, et al.
Archives Internationales De Pharmacodynamie Et De Therapie
|
April 1, 1987
Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril)
T Baum, R W Watkins, E J Sybertz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1981
Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol
T Baum, R W Watkins, E J Sybertz, et al.
Archives Internationales De Pharmacodynamie Et De Therapie
|
April 1, 1987
Angiotensin converting enzyme inhibitory activity of SCH 33844 (spirapril) in rats, dogs and monkeys
E J Sybertz, T Baum, H S Ahn, et al.
Journal of Cardiovascular Pharmacology
|
December 1, 1996
Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitor
S Vemulapalli, R W Watkins, M Chintala, et al.
The Journal of Clinical Investigation
|
February 1, 1997
Diet-induced obese mice develop peripheral, but not central, resistance to leptin
M Van Heek, D S Compton, C F France, et al.
Journal of Medicinal Chemistry
|
April 1, 1988
Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolines
E M Smith, G F Swiss, B R Neustadt, et al.
Obesity Research
|
April 17, 1998
Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats
H R Davis, D E Mullins, J M Pines, et al.
Journal of Cardiovascular Pharmacology
|
July 1, 1983
Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor
E J Sybertz, T Baum, H S Ahn, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
The Journal of Pharmacology and Experimental Therapeutics
|
October 23, 1997
In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461
M Van Heek, C F France, D S Compton, et al.
Journal of Medicinal Chemistry
|
July 22, 1994
Mercaptoacyl amino acid inhibitors of atriopeptidase. 1. Structure-activity relationship studies of methionine and S-alkylcysteine derivatives
B R Neustadt, E M Smith, T L Nechuta, et al.
Archives Internationales De Pharmacodynamie Et De Therapie
|
April 1, 1987
Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril)
T Baum, R W Watkins, E J Sybertz, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
August 1, 1981
Antihypertensive and hemodynamic actions of SCH 19927, the R,R-isomer and labetalol
T Baum, R W Watkins, E J Sybertz, et al.
Archives Internationales De Pharmacodynamie Et De Therapie
|
April 1, 1987
Angiotensin converting enzyme inhibitory activity of SCH 33844 (spirapril) in rats, dogs and monkeys
E J Sybertz, T Baum, H S Ahn, et al.
Journal of Cardiovascular Pharmacology
|
December 1, 1996
Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitor
S Vemulapalli, R W Watkins, M Chintala, et al.
The Journal of Clinical Investigation
|
February 1, 1997
Diet-induced obese mice develop peripheral, but not central, resistance to leptin
M Van Heek, D S Compton, C F France, et al.
Journal of Medicinal Chemistry
|
April 1, 1988
Synthesis and pharmacological activity of angiotensin converting enzyme inhibitors: N-(mercaptoacyl)-4-substituted-(S)-prolines
E M Smith, G F Swiss, B R Neustadt, et al.
Obesity Research
|
April 17, 1998
Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats
H R Davis, D E Mullins, J M Pines, et al.
Journal of Cardiovascular Pharmacology
|
July 1, 1983
Angiotensin-converting enzyme inhibitory activity of SCH 31846, a new non-sulfhydryl inhibitor
E J Sybertz, T Baum, H S Ahn, et al.
Page
of 8